Skip to main content
Top

Clinical & Experimental Metastasis

Issue 8/2002

Content (11 Articles)

A critical review of vascular endothelial growth factor (VEGF) analysis in peripheral blood: Is the current literature meaningful?

E. Hormbrey, P. Gillespie, K. Turner, C. Han, A. Roberts, D. McGrouther, A.L. Harris

Differential assessment of angiogenic activity and of vascular survival ability (VSA) in breast cancer

Alexandra Giatromanolaki, Efthimios Sivridis, Constantinos Simopoulos, Alexandros Polychronidis, Kevin C. Gatter, Adrian L. Harris, Michael I. Koukourakis

Effects of Celebrex and Zyflo on liver metastasis and lipidperoxidation in pancreatic cancer in Syrian hamsters

F.A. Wenger, M. Kilian, M. Bisevac, C. Khodadayan, M. von Seebach, I. Schimke, H. Guski, J.M. Müller

Vaccination of mice with MUC1 cDNA suppresses the development of lung metastases

Mika Kamata, Kaori Denda-Nagai, Nobuyoshi Kubota, Satoshi Aida, Kazuyoshi Takeda, Tatsuro Irimura

EMMPRIN-mediated MMP regulation in tumor and endothelial cells

Stéphanie Caudroy, Myriam Polette, Béatrice Nawrocki-Raby, Jian Cao, Bryan P. Toole, Stanley Zucker, Philippe Birembaut

Modulation of proteolytic potential and differentiation by CNTF and BDNF in two mouse neuroblastoma clones: Relation to invasion

Luigi Sartor, Alessandro Negro, Emanuela Barletta, Gabriele Mugnai, Spiridione Garbisa

Role of integrin αvβ3 in the early phase of liver metastasis: PET and IVM analyses

Hironori Kikkawa, Masako Kaihou, Natsuko Horaguchi, Takayuki Uchida, Hidetoshi Imafuku, Ayano Takiguchi, Yukako Yamazaki, Chieko Koike, Ryoko Kuruto, Takeharu Kakiuchi, Hideo Tsukada, Yoshikazu Takada, Nariaki Matsuura, Naoto Oku

Plasma basic fibroblast growth factor levels in colorectal cancer: A clinically useful assay?

M.L. George, M.G. Tutton, A.M. Abulafi, S.A. Eccles, R.I. Swift

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine